ChemDiv Helps Advance Viriom’s Influenza Treatment to Successful Phase I Clinical Trials Completion
![AV5124 Influenza Virus Replication Inhibitor](https://wellnessnews24.com/wp-content/uploads/2023/12/pexels-polina-tankilevitch-3873146-720x530.jpg)
1 min read
ChemDiv Inc., dedicated to partnering in discovery and development of breakthrough therapies based on its unique chem-bio...